A service that stores a consumer’s immune cells for future anti-aging treatments, sold directly to longevity-focused consumers.
Direct-to-Consumer Longevity Biotech Services
Cellino’s new $5,000 direct-to-consumer immune cell banking launch for longevity-focused consumers suggests people may prepay now for future anti-aging treatments that don’t yet exist. That demand could support subscription, storage and downstream therapy business models by letting consumers preserve their immune cells today in case future therapies can use them.
Projected Score
as a side gig ☆☆☆☆☆ (0/5)
no money or audience ☆☆☆☆☆ (0/5)
with both ★★☆☆☆ (2/5)
Want this one researched? Commission the full dossier for $15: we research and write it, and you read it first. Then you choose — pay more to keep it exclusive, or do nothing and it goes public on this site. The score above is our forecast for a dossier we haven’t written yet.
The news behind it
- Oct 16, 2026 Athletech News: Cellino Launches $5K Immune Cell Banking Service for Longevity-Focused Consumers
